The Polari Labs is removing barriers to intimacy and improving anorectal health. At Polari Group, we believe that the next sexual revolution will be in anorectal health. Currently it takes up to 30 minutes to prepare for anorectal intercourse, using the method called anal douching. This prevents spontaneity and affects romantic relationships. Our team develops category-defining consumer products to make the preparation for anorectal intercourse hassle-free. Anorectal health has been overlooked for too long and the Polari Labs is here to change that.

46 similar entities Type: Startup Activities: healthtech

Notre raison d'être est d'apporter du pep's et de la joie aux personnes dénutries et à risque de dénutrition ! La Picorée est une alternative nutritionnelle pour les personnes à risque de dénutrition, en particulier les personnes qui ont un cancer et les personnes âgées. Nous proposons une nouvelle manière de s’alimenter avec des Pep's, des compléments nutritionnels "à picorer", hyperprotéinés et hypercaloriques, (enfin !) gourmands et naturels ! Nos produits sont particulièrement adaptés aux besoins nutritionnels et aux usages des personnes âgées et malades. Ils sont sous un format « petite bouchée », adaptés au manger-main et aux troubles …

16 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneering rational design of drugs made of defined bacteria consortia that are essential dwellers of the gut ecosystem. The trillions of microbes that call us home –the human microbiome – perform critical functions that preserve our health including helping develop our immune system, manufacturing nutrients such as vitamins, and harvesting energy from the diet. Alterations of the human microbiome are increasingly recognized as a key factor in autoimmune, metabolic, infectious and many other diseases. For millions of years, humans have co-evolved with this community of microbes, communicating in an ancient language that holds critical clues about how autoimmune and infectious …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Next gen skin cancer prevention: Faster, AI-driven, patient-first LemonDocs combines state-of-the-art AI-powered telemedicine with high-quality, physical skin clinics, creating the next generation of dermatology: fast, efficient and always close to people. Our mission is to fight skin cancer by making dermatology more efficient, accessible and patient-focused. From photo uploads to outpatient surgeries, LemonDocs offers a seamless, one-stop process. The advantage? A hybrid model that combines technology and medicine, vertical integration for speed and quality, and a clear focus on the medical and personal experience. The first clinic in Berlin. Many more will follow. Dermatology, Skin Health, Telemedicine, and AI Skin …

220 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Se détoxifier au naturel - la première cure de nettoyage intestinale antiparasitaire naturelle. Cleanse your Gut - Cleanse you body - Cleanse your mind. The Gut Cleanser révolutionne the way you optimise your health by focusing on Cleansing and Detoxification.

28 similar entities Type: Startup Activities: healthtech

Developing mRNA vaccines and therapeutics In September 2021, Sanofi acquired Translate Bio, a clinical-stage mRNA therapeutics company. This acquisition further accelerates Sanofi’s efforts to develop transformative vaccines and therapies using mRNA technology. It adds a critical pillar to the company’s mRNA Center of Excellence, which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We …

144 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Creators of the world's smallest fridge, designed to keep your medication at a constant temperature wherever you may go. Our future is one in which the lives of medication users are not dictated by their health. A future where you have the freedom to take control by using the right tools. ___ Without flawless execution, ingenious ideas might as well remain dreams. We honour our reputation and strive to be industry leaders. In doing so, we keep our small team flexible enough to listen and respond to your needs directly. So, when you speak to one of us, you’re speaking …

51 similar entities Type: Startup Activities: healthtech biotech deeptech

We are committed to your intestinal health | Microbiome test | Research | Knowledge sharing | Personalized advice Take control of your own (intestinal) health 💪 A diverse and balanced microbiome is a healthy microbiome. How you live and what you eat influences this. And we know how better and better. By getting to know your microbiota, you can discover what specifically you can do to improve your intestinal health! 🎯 From relieving intestinal complaints to optimizing your energy, or simply checking whether you are indeed as healthy as you think. You can find this out using a microbiome test. …

39 similar entities Type: Startup Activities: healthtech

Bacteria are everywhere. We tend to see bacteria as our biggest enemies, yet they are also our biggest allies. Microorganisms are so numerous and endlessly adaptable that we will never be able to control them completely. In the past decades, we have come to understand microorganisms better and it convinced human beings to believe that by using biocides, antibiotics, and pesticides we might be able to get control over them. However, this has resulted in the exact opposite: bacteria and viruses developed further and adapted, making them resistant to our control attempts and technologies. Creating resistant superbugs and hard to …

36 similar entities Type: Startup Activities: deeptech Technologies: New Materials

Innovation, precision, and purpose - redefining infection diagnostics for better outcomes. At Noscendo, we save and improve lives by revolutionising infection diagnostics. Through our metagenomic technology DISQVER®, we empower clinicians to identify pathogens rapidly, precisely, and without assumptions — helping patients receive the right treatment at the right time. We believe in a future where infectious diseases no longer claim lives unnecessarily. Driven by our values, we act with openness and reliability, always put patients first, grow and empower each other, and innovate to elevate modern medicine. We take ownership — and deliver results that matter.

87 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field. Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field. Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases. We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.​ Committed to innovation, Da Volterra develops products intended to protect the intestinal …

89 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Art of Glue Hunting A curious team of explorers, deeply rooted in science, and constantly on the lookout for a very particular novel drug modality. This is us – Proxygen. We hunt for glue degraders. They are the key to unlocking new treatments for patients. They revolutionize how we see and cure diseases.

139 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Microbiota biotherapeutics and Vaccines company. Conditioning the gut ecosystem for disease prevention and therapy. Spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, aimed at shaping the intestinal microbiota for the cure and prevention of diseases such as bowel diseases and cancer. The gut ecosystem conditions the function of all our organs and plays a fundamental role in our wellbeing. The mucosal immune system has co-evolved with the intestinal microbiota to adapt its function to a number of environmental and possibly pathogenic factors. MV Bio leverages a microbiota-mediated mechanism regulating the physiological response of the intestinal …

55 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Nordic Infucare started its journey as an entrepreneurial company with the desire to do things differently. Mats Bergryd founded the business to offer specialized treatments in a home environment, serving patients who suffer from chronic disease. He chose that niche as he, after 20 years in the industry, had identified a gap between what was possible to achieve with smart technology and pharmaceuticals, and the actual results. Mats concluded that there was an opportunity to increase the quality of life for patients with chronic disease by closing the gap, and that it would be good business for the one who …

252 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in …

137 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Why replace antibiotics when we can make them work better? AI matches the bacterial genome to an adjunct - Phages first Why replace antibiotics when we can make them work better? Resistance often doesn't mean an antibiotic is finished — it means it needs a partner. We are the AI infrastructure layer that finds that partner in minutes, not months - starting with phages. Our platform reads the bacterial genome of a resistant isolate and returns the adjunct most likely to restore the antibiotic's response — ranked, scored, and confirmed by the ordering laboratory before any clinical use. Minutes, not …

81 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Passion for Innovation. Compassion for Patients. Daiichi Sankyo is a global healthcare company committed to becoming a trusted healthcare innovator, transforming the lives of people through its strength in science and technology. The company discovers and develops new standards of care to address diverse medical needs to fulfill its purpose of contributing to the enrichment of quality of life around the world. With a strategic focus on oncology, Daiichi Sankyo is advancing an industry-leading antibody drug conjugate portfolio along with identifying new breakthrough generating technologies to deliver practice-changing medicines to patients, healthcare professionals and society. Daiichi Sankyo Europe GmbH operates …

89 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

You are 50% bacteria*. Care for them * Not an insult You are a planet. You are made up of human cells and of billions of bacteria living together in perfect harmony. If you look after them, they will look after you. At Gallinée we are the world’s first skin and haircare line dedicated to the health and wellbeing of Planet You. Your skin is made up of 1000s of good bacteria which form the protective layer called the microbiome. If the microbiome becomes unbalanced or stripped away, then your skin becomes inflamed and sensitive. Does this ring a bell? …

79 similar entities Type: Startup Activities: biotech deeptech cosmetics Technologies: Bio sourced materials

At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD …

208 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

We're on a mission to help you take control of your digestive health and trust your gut! Bloated after eating? Feeling sluggish? Tired of feeling like sh!t? It's time to get real. Diagnosis or no, are you really doing all the right stuff for your gut? Improving your gut health can start now. Gut Wealth www.gutwealth.co.uk is here to help you. Let's go! ABOUT GUT WEALTH We're on a mission to help you trust your gut. A bold statement, right? But what does it mean? Well, we want to empower you to take control of your digestive gut health through …

28 similar entities Type: Startup Activities: healthtech

Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused …

278 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Elevating the health and beauty of life GENEL is an international French biotech company that offers expert multi-disciplinary services to Dermo-Cosmetic, Nutraceutique and Pharmaceutical companies. We support our clients by identifying the right commercial strategy for the successful launch of their product. GENEL for Cosmetics, Dermo and Nutraceutique: Works hand in hand with you to build the unique story of each of your ingredients, and thus elevate the specialty and values of your brand. Thanks to more than 10 years expertise in Skin Homeostasis and in Functional Genomics, we specialize in assisting companies like you that are in the Dermo- …

140 similar entities Type: SMB Activities: deeptech biotech

Focused on the Few Social media guidelines: http://www.recordatirarediseases.com/social-media At Recordati Rare Diseases, we focus on the few - those affected by rare diseases. We believe that every single patient has the right to the best possible treatment. Patients with rare diseases are our top priority. They are at the core of our planning, our thinking and our actions. Social Media Guidelines: http://www.recordatirarediseases.com/social-media Rare Diseases, Orphan Drugs, Metabolic Diseases, Lysosomal Disorders, Rare Cancers, and Endocrinology

133 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Plants and vitamins in Spray ✅ More effective. ✅ More suitable for everyday life. What are the benefits? It is above all a human adventure, the meeting between Julien the pharmacist and Valentin in a large French health group. Both passionate about herbal medicine and the benefits of plants and vitamins on our health, we wanted to create, for you, as for ourselves, ultra-effective products, of natural and eco-responsible origins. The benefits are therefore a French brand which wishes to revolutionize the taking of food supplements by facilitating their daily use and optimizing their effectiveness. It all started from a …

132 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

AI-Native Phage Therapy We are facing a global crisis where bacterial infections are becoming increasingly deadly due to antibiotic resistance. The health and economic consequences are staggering, with bacterial disease predicted to be the #1 cause of death by 2050. Alternatives are urgently needed, but nature already has its solution: phages, the natural predators of bacteria. At Phagos, we are bringing back phage technology by combining advances in microbiology with cutting-edge artificial intelligence. Our patented technology makes large-scale, customized phage-based veterinary medicines possible for the first time. And soon we'll universalize the technology for human health too. Our mission is …

65 similar entities Type: Startup Activities: biotech healthtech Technologies: Decarbonization

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The reference for belly well-being. DIJO - WELL-BEING THROUGH THE BELLY We have developed a range of natural products from probiotics 🦠, herbal medicine 🌿 and micronutrition 🔎 to maintain and optimize stomach health! OUR MISSION Make your stomach your priority and above all help you take care of it every day. The stomach is the pillar of our health, it regulates absolutely everything: our digestion, our moods, our skin, our weight and our immune system. Yet today 1 in 2 French people are affected by stomach problems with consequences on their general health. We have developed a range of …

133 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

Chicory reinvented: the French & healthy alternative to coffee 🇫🇷🌱 Discover your new ritual! Our mission since 2020? Help you reduce caffeine by bringing chicory back into fashion in a 100% organic and made in France version. Aware of the side effects of stimulants on our health, more and more of us want to reduce their consumption. But also to want to preserve the planet by favoring short circuits. Today it is possible and it is happening nearby, in France, with chicory. Discover a highly flavorful product: 🇫🇷 manufactured using unique French know-how 🌱 100% plant-based ⭐ with beneficial nutritional …

149 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

Empowering the Health Microbiome Movement The gut microbiome (i.e: the microorganisms present in our intestine) plays a major role in maintaining our health. In case of dysfunction, the microbiome is linked to a large number of inflammatory, metabolic, and neurological diseases. The study of the microbiome opens many perspectives for tomorrow’s medicine. Pelican Health offers a solution enabling multiple sampling of the microbiome in-situ with a single oral administration, in a reliable, precise, simple to administer and non-invasive manner.

47 similar entities Type: Startup Activities: deeptech

Medicine is an art, at the crossroads of several sciences. We want to help others... to help others. We want each patient to benefit from the best possible care, thanks to rapid, efficient and appropriate care. - No overconsumption of unnecessary care. - Accurate diagnoses, at the right time. - An optimized health journey to live a long, healthy life, without thinking about it. Our mission Simplify the work of healthcare professionals, by digitalizing the care pathway and associated processes, but also thanks to expert prevention tools, personalized health checks and diagnostic assistance. We allow them to focus on the …

499 similar entities Type: Startup Activities: healthtech Technologies: A.I. - Natural Language Processing Generative A.I. A.I.

goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from Université Côte d'Azur, INSERM and CNRS focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, …

171 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

AI-powered preventive care that turns diabetes data into action-for patients, preventive providers,insurers and pharma. 537 million people live with diabetes. 6.7 million die from it every year. The global economic burden exceeds $966 billion annually, with complications driving 2.3x higher costs. And yet, most interventions still come too late — when the damage is already done. At MEROVA, we’re changing this. We built an AI-powered preventive ecosystem that tackles diabetes at its root — before complications develop, before costs escalate, before lives are lost. Every food choice reflected. Every blood sugar pattern understood. Every intervention recorded. Prevention isn’t just better …

142 similar entities Type: Startup Activities: healthtech Technologies: SaaS

Engineering Biological Alpha Pheiron is an applied AI lab dedicated to Biological Alpha: the ability to know what biology will work in humans early enough to change the outcome of a drug program. We underwrite biology risk against clinical outcomes and use the edge to select and develop drug programs with the highest probability of success. At today's pace, humanity will wait 500 years for every known disease to have a cure. Twenty generations of patients. Pheiron compresses this timeline by radically increasing the drug-per-dollar output. 500 years is too long. We publish predictions on selected upcoming clinical readouts to …

70 similar entities Type: Startup Activities: healthtech it services Technologies: A.I.

Microbial solutions and microbiome skincare with live bacteria In Lactobio we focus on the creation of new microbiome and microbial solutions to target and fight the problem of increasing infections caused by microorganisms being resistant to antibiotics. We work with the skin, vaginal, and gut microbiota to treat a variety of diseases – with projects spanning various pathogens. Lactobio has obtained very promising clinical results, with isolated lactic acid bacteria having a significant antibacterial activity against Staphylococcus aureus, Methicillin Resistant Staphylococcus aureus (MRSA) and other pathogens.

55 similar entities Type: Startup Activities: deeptech biotech

Ferryx develops next generation probiotics which are transforming gut health for people with IBS Ferryx is a biotechnology company developing next generation probiotics that work during inflammation or stress, which most probiotics can't. Our lead product, Ferrocalm, is a scientifically validated supplement designed to support gut health, particularly for people with irritable bowel syndrome (IBS). Ferrocalm is the first probiotic designed to work during IBS flare-ups, not just in between. Backed by science, it helps reduce symptoms right when they're at their worst. Food supplements, Probiotics, and Consumer healthcare

34 similar entities Type: Startup Activities: healthtech

Return to your calling. Doctors didn't study medicine to fix documentation. But in most European hospitals, that's where a frightening amount of their time goes — piecing together records that are incomplete, inconsistent, sometimes plain wrong. Not because anyone is careless. Because the infrastructure was never built to keep up. We know this firsthand. Our co-founder Sven is a physician. He lived it. He still spends his time in the hospitals we serve, sitting with care teams, understanding where things break. That's not a sales motion — it's how we build. aiomics is a clinical data intelligence platform. We sit …

202 similar entities Type: Startup Activities: healthtech Technologies: A.I.

Reinventing the medical needle Xaga Surgical’s mission is to minimize the risk of infections by inventing safer medical needles. Our needles focus on the very core of infection prevention: reducing bacterial transmission into the body. Widespread antibiotic resistance means that novel approaches for infection prevention are desperately needed. We develop patented and patent pending medical needles designed for a wide range of situations where there is a risk of infection. For example, prostate cancer is diagnosed using a biopsy needle. Up to 3% of biopsy procedures lead to sepsis, a life-threating infection, and this number is on the rise. The …

60 similar entities Type: Startup Activities: healthtech deeptech

Our mission for +25 years is to take care of people's health with an eye toward the future and innovation. We are moved by values ​​such as commitment, honesty and the desire to improve. Thanks to them and our team we have become the 3rd pharmaceutical laboratory that sells the most units in Spanish pharmacies. We are also pioneers in biosimilar drugs in Spain and Portugal and we also have a line of self-care products, sports nutrition under the Finisher brand and women's health under the Gynea brand. Our vocation to serve society means that we are always close to …

271 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Healthcare is complicated. Care doesn't have to be. Pakistan's First Managed Care Company. Your employees are navigating Pakistan's fragmented healthcare system alone. Up until now, no one has been coordinating care between their doctors. No one is managing their multiple prescriptions or considering contraindications and potential adverse events linked to combining various medicines. No one is following up on the patient. Healthcare is treated like a vending machine — put money in, get a consultation out. doctHERs changes that. We are the care team you deploy for the people you reach — employees, factory workers, patients, communities. We manage their …

286 similar entities Type: Startup Activities: healthtech Technologies: SaaS

At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of …

60 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Greatest Wealth is Health® Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who we are: At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. Values we live by: Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive …

72 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology Data Analytics

Prescription digital therapeutics powered by personalized nutrition. Reimagining medicine At Perfood, we translate state-of-the-art data and medical science into therapy. We create software, that precisely identifies what actions need to be take on a personalized level, to prevent or fight diseases. Using sensors, lab results and holistic analyses, we derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. We call this approach digital therapeutics. A digital solution that is just as effective as a drug. But without side effects. We believe that our genetic heritage is an elementary compound of our health. …

101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Support gut health with one capsule a day. Do it daily to boost digestion, energy, and overall wellness. mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers. Microbiome, Guthealth, Probiotics, …

42 similar entities Type: Startup Activities: healthtech

We cultivate reciprocal relationships with anyone who crosses our path We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals. Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions. Our name reflects our story: The Napo River crosses the territories of the Amazon where the Croton lechleri tree grows – the plant from which we extract the sap that contains a precious active ingredient. We are investigating an innovative and first-in-class drug thanks to the …

187 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing a medicine that increases food intake Orexa is a phase 2 pharmaceutical company that develops and commercializes therapeutics to increase food intake. Its lead compound ORE-001 is a proprietary oral formulation, based on a well known anesthetic. The company has started its first phase 2a study in the Prevention of Post-Operative Ileus. Furthermore it is in preparation for phase 2a studies in Anorexia and Cachexia. With these three indications increased food intake could lead to an improved patient health, a shorter hospital stay and significant cost savings. Orexa was founded in 2016 and is headquartered in Herpen (Oss Region, …

123 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology

We're changing the trajectory of human health, one baby at a time. Intent on a world without debilitating disease. Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of breast milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to …

49 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. - Machine Learning

AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10TM, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and …

225 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We Use Food Waste And Plant Matter To Help Improve & Change Lives Dear Linkedin Member, I extend a warm and sincere welcome to you, our valued guest, as you explore the Letoon Holding Ltd platform. Our mission is one that we hold close to our hearts: to generate healthy profits for our investors within the framework of a circular economy. At Letoon Holding Ltd, we are committed to addressing critical global challenges head-on. Our focus lies in tackling three significant issues: 1. The Global Food Waste Epidemic: It's astonishing that food waste accounts for an estimated $1 trillion, which …

174 similar entities Type: Startup Activities: deeptech cleantech Technologies: SaaS

Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products especially in areas where these needs are unmet. The human population is growing and also the life-span is increasing. Many children born today can be expected to live until they are about 100 years old. By these reasons it can be expected that the need for efficient therapies for treatment of different diseases will …

94 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Technology to go from data to plate Biotasmart | Revolutionizing intestinal well-being with science and technology At Biotasmart, we believe that a balanced microbiota is the key to a healthier life. Through science and technology, we offer advanced gut microbiota analysis and personalized advice to help you optimize your well-being from the root. 🔬 What do we do? We analyze your microbiota to understand its impact on your health. We provide detailed reports with actionable information. We offer nutritional advice based on scientific evidence. 🌱 Why does intestinal health matter? Your gut is home to trillions of microorganisms that influence …

32 similar entities Type: Startup Activities: deeptech Technologies: Data Analytics

Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive Outcomes. Positive Patient Stories®. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that …

71 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Taking care of maintaining your health so that you can live your future is our goal. Laboratorios Heel España S.A.U., Spanish subsidiary of the multinational pharmaceutical group of German origin Heel, stands out for its focus on the search, through research, for new active ingredients of natural origin and/or innovative pharmaceutical forms that can improve people's quality of life. Taking care of maintaining your health so that you live for the future is our goal. Within the new lines of research that we promote, the microbiota and its relationship with health is one of the most important. More information at …

143 similar entities Type: SMB Activities: healthtech Technologies: Bio sourced materials

We Relieve so you can Relive Our team of medical professionals are there to actually listen to the patients and to work together so they can live a painfree life. Neurologist, anesthesiologists, neuropsychologist and orthomolecular nutritionists all working as a team to fully understand the issues at hand. Starting from bloodwork, intestinal microbiome to DNA analysis over echo controlled infiltrations with PRP. Our approach is like nothing you've experienced before. Yes, there are always other possibilities and no, we don't believe that when all 'traditional' approaches fail it must be 'all in your head'. More info? info@relieveclinic.be painmanagement, neurology, anesthesiology, …

178 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Discovering the Beauty Within Nutrition isn’t complicated. For us, it’s natural. We’ve been a leader in the research and development of carotenoid-based products for the last two decades and we take that role very seriously. This means we approach everything we do with a sense of wonder and a driving desire to find the best possible outcome or create the highest-quality product. Sometimes we begin with an actual seed (from one of our tomato farms) and sometimes we start with the seed of an idea—maybe a health-related concern or even a question that was posed by one of our scientists …

66 similar entities Type: SMB Activities: healthtech biotech Technologies: Bio sourced materials

Even today many patients can’t effectively be treated with the standard of care. Most patients don’t want to wait many years until new therapies become available. They want to take action. They want to contribute to the medical progress. Viomedo connects patients with medical research in order to help improve existing therapies and find cures. We are the leading platform for medical research in the German speaking region. Together with researchers, patient support groups, research hospitals and pharmaceutical companies we want to transform medical research all over Europe. Viomedo - tomorrow’s medicine, today. Patient Recruitment, Clinical Trials, Internet, Innovative Treatments, …

105 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Unlocking the full potential of genetic medicines. At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization …

126 similar entities Type: Incubators & VCs Startup Activities: biotech deeptech Technologies: Synthetic Biology

The UK's leading sepsis charity, raising awareness of the condition and providing vital support to people affected. Many people have never heard of sepsis, or if they have, people are often confused about what it is, and what signs to look out for. However, sepsis kills 48,000 people in the UK every year, which is more than breast, bowel and prostate cancer deaths combined. If it isn’t treated immediately as a medical emergency, it can take someone’s life in under 24 hours. Sepsis is the body’s over-reaction to an infection or injury, which causes the immune system to attack its …

51 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: healthtech edtech fintech

Spécialiste des solutions sensorielles et fonctionnelles pour le mieux-être Born in 1996 from a passion for science and the conviction that scents have the power to improve well-being, Phodé is an independent French group based in the south of France. Pioneer of the link between olfaction and behaviour, we design sensory formulations and plant-based active ingredients that combine well-being, pleasure and performance — across animal nutrition, food & nutraceuticals, and the olfactory environment. Innovation is our heartbeat. Working hand in hand with international research institutes and universities, our teams use cutting-edge tools — brain imaging, microbiology, behavioural science — to …

149 similar entities Type: SMB Activities: biotech Technologies: Bio sourced materials

Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, we approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Before symptoms present, before irreversible damage is done to the bodies, minds, and lives of patients and families, and before it’s too late —this is where we operate. Our lead investigational product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of clinical type 1 diabetes in at-risk individuals. …

81 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Investing dark biodiversity DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the microbial dark matter. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE (antibiotics, antifungals, antivirals and antiparasitics) target superbugs (microbes that resist to one or several antimicrobials) that cause life-threatening infections which are now spreading at high speed. This breakthrough approach gave birth to one of the World first specialized micro-biotechnology platforms and a unique collection …

72 similar entities Type: SMB Activities: biotech deeptech

A Sundew company We are creating a potentially revolutionary algal platform technology. Thanks to major advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. The cost of the synthetic biology tools has dropped. We are building our technology based on solid, peer-reviewed science[1][2][3][4]. By using microalgae as an oral delivery vehicle, we can substantially cut the labor and post-processing production costs, allowing us to produce effective vaccines that are much more affordable and user-friendly. Our technology can reduce or eliminate the use of antibiotics, reduce fish mortality rates …

89 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Modulating innate immunity to improve cancer therapy outcomes. . Akthelia Pharma is a late preclinical-stage immunotherapy company, with its HQ in Iceland, targeting a huge unmet opportunity to improve cancer and cell/organ transplant outcomes through reducing the risk of neutropenic sepsis. This potentially fatal complication of systemic anticancer treatment, where a combination of reduced neutrophil count and loss of GI integrity results in bacteremia from the patient's own microbiome, is the leading cause of death associated with chemotherapy (up to 20% mortality) -- other than disease progression. Our breakthrough patented strategy, which is supported by world-leading KOLs, is to specifically …

84 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Striving to improve and extend patients' lives Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to …

174 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

BaseClear offers genomics expertise and consultancy to accelerate the understanding and use of microorganisms. Microbes have a huge potential to contribute to the solution of a large number of issues facing the modern world, ranging from antibiotic resistance and personal disease to poor crop yields and problems caused by global warming. For years, relatively little was known about the often-invisible world of microbes. However, the latest DNA technologies have provided tools to really see what is happening inside microbes and within microbial communities. This allow us to unravel the interactions between microbes and their hosts and environment. BaseClear, founded in …

73 similar entities Type: SMB Activities: biotech deeptech

Pharmaceuticals and cosmetics: two great Italian traditions. We renew them every day. Zeta Farmaceutici Group is an Italian industrial reality made up of a group of companies specialized in the development, production and distribution of drugs, medical devices, cosmetics, food supplements, biocides. 1. Production and marketing of products with own brands. Our brands are present in 10,000 pharmacies and parapharmacies, with widespread distribution throughout Italy. 2. Contract manufacturing. Industrial partnership with national and international companies and groups. Our brands. Euphidra. Make up, dermoscomesis, hair coloring, personal hygiene. Amido Mio. The rice starch line to cleanse and protect the most sensitive …

146 similar entities Type: SMB Activities: cosmetics deeptech manufacturing Technologies: Synthetic Biology